Investment Disclosure
Please read this Investment Disclosure carefully. It applies to all content on merovacam.com (the "Site"), operated by GRAY LLC, doing business as Merovacam ("Merovacam," "we," "us").
1. No Offer or Solicitation
Nothing on this Site constitutes, and should not be construed as, an offer to sell, or a solicitation of an offer to buy, any security, interest in a fund, or other investment product, in any jurisdiction where such an offer or solicitation would be unlawful. Any offer of securities, if made, will be made only through definitive offering documents, and only to persons who satisfy applicable eligibility requirements, such as "accredited investor" status under Regulation D of the Securities Act of 1933, as amended.
2. Not Investment, Legal, or Tax Advice
Information on this Site, including any sector overviews, insights articles, or descriptions of our investment process, is provided for general informational purposes only. It does not take into account the investment objectives, financial situation, or particular needs of any specific person or entity, and should not be relied upon as investment, legal, tax, or accounting advice. You should consult your own professional advisors before making any investment or business decision.
3. No Guarantee of Returns or Outcomes
Venture capital investing involves a high degree of risk, including the risk of total loss of invested capital. There is no guarantee that any investment made by Merovacam, or by any company in which Merovacam invests, will achieve its objectives or generate any particular return. Past investment activity, portfolio composition, or any individual portfolio company's success is not indicative of, and does not guarantee, future results for Merovacam, its portfolio, or any other company.
4. Forward-Looking Statements
Statements on this Site regarding sectors, trends, market opportunity, or the future prospects of Merovacam or its portfolio companies may constitute forward-looking statements. These statements are based on current expectations and assumptions that are subject to significant business, economic, regulatory, and competitive uncertainties. Actual results may differ materially from those expressed or implied. Merovacam undertakes no obligation to update any forward-looking statement.
5. Illiquidity & Risk of Loss
Investments in early-stage, privately held companies are illiquid, speculative, and involve a high degree of risk. There is typically no public market for securities of early-stage companies, and investors should be prepared to hold such investments for an indefinite period and to bear the risk of losing their entire investment.
6. Portfolio Companies Are Independent
Portfolio companies referenced on this Site are independently owned and operated businesses. Their inclusion on this Site is not, and should not be interpreted as, an endorsement of Merovacam by any portfolio company, nor an endorsement by Merovacam of any portfolio company's products, services, or securities. Company names, logos marks, and descriptions used on this Site are illustrative and used for descriptive purposes only.
7. Submissions Are Not Confidential by Default
Unless we have separately executed a non-disclosure agreement with you, materials submitted to Merovacam through this Site (including pitch decks and business information) are not treated as confidential or proprietary, and submission does not create any fiduciary, advisory, or other special relationship between you and Merovacam.
8. Regulatory Status
Merovacam engages in venture capital investment activity. Nothing on this Site should be understood to represent that Merovacam or any of its personnel is registered as a broker-dealer, investment adviser, or in any other regulated capacity, except where such registration or exemption status is separately and explicitly disclosed to a specific prospective investor through definitive offering documentation.
9. Related Policies
This Investment Disclosure supplements and is incorporated into our Terms of Service. See also our Privacy Policy.
10. Questions
Contact us at info@merovacam.com with any questions about this disclosure.